Study Shows Connection Between ADHD Medication and Risk of Suicide Attempt
Risk of suicide attempt is higher among adults, women.
Eisenhower Fellowships Launches 2022 USA Justice Program With Psychiatric Fellow
Cohort includes professionals from multiple fields, including psychiatry and medicine.
$5.3 Million in Grants Awarded to Address Youth Mental Health Crisis
Inaugural recipients will use funds to support infrastructure, student mental health, and programs for children with behavioral challenges.
Migraine and Mental Health: Patients, Health Care Professionals Share Their Perspectives
Survey results addressed connections between migraine and mental health, stigma, and treatment preferences.
Brain Inflammation May Link Alzheimer Disease With Sleep Disturbance
Study shows promising results for early detection and prevention efforts.
Social Determinants of Mental Health and Clinical Updates Featured at Meeting
Did you miss the American Psychiatric Association 2022 Annual Meeting? We've got you covered.
Complementary Effects of Combined Alternative Treatments on Social Anxiety Disorder
Treatments alter the neural processes underlying SAD symptoms.
New Chemical Entity Improves Symptoms in Individuals With Treatment-Resistant Schizophrenia
Interim study results show 77% treatment response rate among participants.
The Youth Mental Health Crisis: Supporting Patients With ASD and ADHD
How can we help this unique patient population thrive? Experts weigh in at the 2022 APA Annual Meeting.
Willpower and ADHD
Experts discuss the role of motivation and willpower in ADHD at the 2022 APA Annual Meeting.
Neurological and Neuropsychiatric Complications of COVID-19
An expert discusses the effects of long COVID on the brain at the 2022 APA Annual Meeting.
Cults in the Age of Influence
Experts discuss appropriate interventions for patients who are victims of undue influence at the 2022 APA Annual Meeting.
Leading the Artificial Intelligence Revolution
Experts discuss psychiatry’s role in the advancement of AI technologies at the 2022 APA Annual Meeting.
Assessing Gaps and Opportunities in ECT, rTMS, and DBS Guidelines
The 2022 APA Annual Meeting highlights the latest guidelines for these treatments, plus recommendations for updates and improvements.
Clearing the ‘Brain Fog’ in Long COVID
Experts address cognitive dysfunction found in patients with long COVID at the 2022 APA Annual Meeting.
Understanding the Neurobiology of PTSD
How can we more effectively help patients with PTSD? Charles B. Nemeroff discusses the diagnosis, epidemiology, and pathophysiology of PTSD, along with current and emerging treatments, at the 2022 APA Annual Meeting.
Major Diagnostic Differences Between DSM-5 and ICD-11
Do classification systems make a difference? A presentation at the 2022 APA Annual Meeting noted 4 key diagnoses that differ significantly in the classification systems.
Chester M. Pierce Human Rights Award Winner to Give Inaugural Award Lecture at 2022 APA Annual Meeting
This year’s winner is a pioneer for the human rights of individuals with mental illness in West Africa.
Study Examines Relationship Between Methylphenidate and Risk of Depression
Investigators observed higher levels of depression in children and adolescents with ADHD during MPH treatment.
Study Examines Best Practices for Managing Perinatal Depression
Recommendations are often vague, contradictory, according to investigators.
Study Explores Link Between ADHD and Internet Gaming Disorder
Some of the more severe ADHD symptoms noted were depression/withdrawal, problems with socialization.
Phase 3 Study on Treatment of Agitation in Alzheimer Disease Doses First Patient
Top-line data for study is expected in late 2022, early 2023.
Study Shows 2 in 5 Adults with ADHD are in Exceptional Mental Health
Physical activity, marital status among factors contributing to complete mental health among participants.
FDA Approves Novel Nonstimulant for Treatment of ADHD in Adults
Approval comes 1 year after the drug was approved for the treatment of ADHD in children and adolescents.
Support Gathers for Biden Administration’s 2022 National Drug Control Strategy
Strategy highlights plans of action to address untreated addiction, overdose epidemic.
Individuals Cite Exercise, Gaming as Top Ways to Address Mental Health Issues
The most common issues during the COVID-19 pandemic included stress, anxiety.
APhA Conference Addresses Depression, Benzos
Catch up on all the latest from the American Pharmacists Association (APhA) Annual Meeting & Exposition.
FDA Sends Warning to Websites Over Illegal Sale of Adderall
The warnings cite consumer risks, as well as FD&C, RHA violations.
Study Identifies Urgent Need for More Research on Pain in Severe Mental Illness
Evidence review focuses on bipolar disorder, psychosis, and major depression.
In Case You Missed It: Medical World News Season 5
In Season 5, the psychiatric community weighed in on everything from finding meaning in music to the importance of mindfulness.
2 Clarke Drive Cranbury, NJ 08512